Works matching IS 2160763X AND DT 2020 AND VI 9 AND IP 4

Results: 12

Pharmacokinetics and Immunogenicity of ASP0113 in CMV‐Seronegative Dialysis Patients and CMV‐Seronegative and ‐Seropositive Healthy Subjects.

Published in:

Clinical Pharmacology in Drug Development, 2020, v. 9, n. 4, p. 444, doi. 10.1002/cpdd.792

By:

Bonate, Peter L.;
Van Sant, Charles;
Cho, Kathy;
Zook, Erin C.;
Smith, Larry R.;
Boutsaboualoy, Sou;
Ye, Ming;
Wang, Xuegong;
Wu, Ruishan;
Koester, Anne;
Rammelsberg, Diane;
Goldwater, Ronald;
Marbury, Thomas C.

Publication type:

Article

Thorough QTc Study of a Single Supratherapeutic Dose of Relebactam in Healthy Participants.

Published in:

Clinical Pharmacology in Drug Development, 2020, v. 9, n. 4, p. 466, doi. 10.1002/cpdd.786

By:

Boundy, Keith;
Liu, Yang;
Bhagunde, Pratik;
O'Reilly, Terry E.;
Colon‐Gonzalez, Francheska;
Friedman, Evan J.;
Lala, Mallika;
Rhee, Elizabeth G.;
Rizk, Matthew L.

Publication type:

Article

A Two‐Sequence, Four‐Period, Crossover, Replicate Study to Demonstrate Bioequivalence of Warfarin Sodium Tablet in Healthy Chinese Subjects Under Fasting and Fed Conditions.

Published in:

Clinical Pharmacology in Drug Development, 2020, v. 9, n. 4, p. 527, doi. 10.1002/cpdd.783

By:

Hu, Chaoying;
Chen, Xiaoping;
Zhao, Zirun;
Gao, Dan;
Gong, Shili;
Zhang, Lizhi;
Xu, Yongpeng;
Li, Lin;
Zhang, Lan

Publication type:

Article

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of a Liver‐Targeting Acetyl‐CoA Carboxylase Inhibitor (PF‐05221304): A Three‐Part Randomized Phase 1 Study.

Published in:

Clinical Pharmacology in Drug Development, 2020, v. 9, n. 4, p. 514, doi. 10.1002/cpdd.782

By:

Bergman, Arthur;
Carvajal‐Gonzalez, Santos;
Tarabar, Sanela;
Saxena, Aditi R.;
Esler, William P.;
Amin, Neeta B.

Publication type:

Article

Bioavailability of Triprolidine as a Single Agent or in Combination With Pseudoephedrine: A Randomized, Open‐Label Crossover Study in Healthy Volunteers.

Published in:

Clinical Pharmacology in Drug Development, 2020, v. 9, n. 4, p. 486, doi. 10.1002/cpdd.777

By:

Febbraro, Salvatore;
Shea, Tim;
Cravo, Ana Santos

Publication type:

Article

Absolute Bioavailability of Vemurafenib in Patients With BRAF<sup>V600</sup> Mutation–Positive Malignancies.

Published in:

Clinical Pharmacology in Drug Development, 2020, v. 9, n. 4, p. 496, doi. 10.1002/cpdd.773

By:

Zhang, Weijiang;
Colburn, Dawn;
Simmons, Brian;
Papai, Zsuzsanna;
Bertran, Enric;
Schadt, Simone;
Husser, Christophe;
Forbes, Harper;
Roethlisberger, Dieter;
Hartung, Thomas

Publication type:

Article

Pharmacokinetics of Cenobamate: Results From Single and Multiple Oral Ascending‐Dose Studies in Healthy Subjects.

Published in:

Clinical Pharmacology in Drug Development, 2020, v. 9, n. 4, p. 428, doi. 10.1002/cpdd.769

By:

Vernillet, Laurent;
Greene, Stephen A.;
Kamin, Marc

Publication type:

Article

Lack of Effect of Rezafungin on QT/QTc Interval in Healthy Subjects.

Published in:

Clinical Pharmacology in Drug Development, 2020, v. 9, n. 4, p. 456, doi. 10.1002/cpdd.757

By:

Flanagan, Shawn;
Goodman, Daniel B.;
Jandourek, Alena;
O'Reilly, Terry;
Sandison, Taylor

Publication type:

Article

A Pharmacokinetic Bioequivalence Study Comparing Sublingual Riluzole (BHV‐0223) and Oral Tablet Formulation of Riluzole in Healthy Volunteers.

Published in:

Clinical Pharmacology in Drug Development, 2020, v. 9, n. 4, p. 476, doi. 10.1002/cpdd.747

By:

Qureshi, Irfan;
Lovegren, Meghan;
Wirtz, Victoria;
Larouche, Richard;
Tanguay, Mario;
Anderson, Matt S.;
Hartmann, Sonja;
Coric, Vlad;
Berman, Robert M.

Publication type:

Article

Comparing the Pharmacokinetics of 2 Novel Intravenous Tramadol Dosing Regimens to Oral Tramadol: A Randomized 3‐Arm Crossover Study.

Published in:

Clinical Pharmacology in Drug Development, 2020, v. 9, n. 4, p. 537, doi. 10.1002/cpdd.746

By:

Lu, Lucy;
Ryan, Michael;
Harnett, Mark;
Atiee, George J.;
Reines, Scott A.

Publication type:

Article

Clinical Evaluation of the Tolerability and Pharmacokinetics of Azilsartan, a Potent Angiotensin Receptor Blocker, in Healthy Chinese Subjects.

Published in:

Clinical Pharmacology in Drug Development, 2020, v. 9, n. 4, p. 505, doi. 10.1002/cpdd.735

By:

Li, Xiaojiao;
Liu, Jingrui;
Sheng, Changcheng;
Chen, Hong;
Cui, Dongyang;
Chen, Guiling;
Zhang, Hong;
Zhu, Xiaoxue;
Wu, Min;
Li, Cuiyun;
Shen, Zhenwei;
Guo, Yingjie;
Ding, Yanhua;
Jiao, Zheng

Publication type:

Article

Issue Information.

Published in:: Clinical Pharmacology in Drug Development, 2020, v. 9, n. 4, p. 423, doi. 10.1002/cpdd.678
Publication type:: Article